Decoy Therapeutics与Quantori达成战略合作 部署谷歌云原生AI驱动多肽设计与分子模拟平台

美股速递
Mar 11

Decoy Therapeutics Inc(简称Decoy Therapeutics)宣布与Quantori建立战略合作伙伴关系,双方将共同部署基于谷歌云原生技术的集成式人工智能驱动多肽设计与分子模拟平台。该合作旨在通过先进的计算生物学技术加速创新疗法的开发进程。

此次合作将整合Decoy Therapeutics在生物医药领域的专业优势与Quantori在人工智能和云计算方面的技术积累,打造高效协同的药物研发解决方案。平台将利用谷歌云的基础架构,实现多肽药物设计的自动化优化与分子层面的精准模拟。

这一战略部署标志着双方在AI驱动药物研发领域迈出关键一步,有望为复杂疾病治疗带来突破性进展。通过云端平台的协同创新,合作伙伴计划提升药物发现效率,缩短研发周期,为患者提供更精准的治疗方案。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10